The next generation of immunotherapy? Innate Pharma targets NK cells
pharmaphorum
APRIL 9, 2021
Founded in 1999, Marseille-based company Innate Pharma is on a mission to develop immunotherapies that take advantage of the body’s innate immune system. The cytokine release prompts T-cells so they can translate that first innate immune response into a long-lasting adaptive immune response. About the interviewee.
Let's personalize your content